Another controversial paper from Surgisphere gp which published in Lancet on HCQ assoc. mortality
1. Highly implausible Massive Mortality benefit for Ivermectin HR 0.2(0.11-0.37)
2. Didn't know 407 Patients in US used Ivermectin before 31st March? (I saw first reports in April)

Unless this group at least gives access to data (which they have refused) ,I refuse to trust any analysis from this group. Paper here..

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3580524

A group of surgeons doing analysis with massive confounding with a company found few months back that uses data shared by hospital without ethical board review.
Groups unrepresentative of population,Numbers from countries not believable.

EHR databases were supposed to be elixir of "personalised" science. However research on them is turning out to be flawed, unscrupulous checking every box in flawed research.